SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001213900-20-037777
Filing Date
2020-11-17
Accepted
2020-11-17 17:28:56
Documents
16

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO FORM F-1 ea130034-f1a4_nlspharma.htm F-1/A 2092837
2 CONSENT OF MARCUM LLP. ea130034ex23-1_nlspharma.htm EX-23.1 2240
3 GRAPHIC image_001.jpg GRAPHIC 14073
4 GRAPHIC image_003.jpg GRAPHIC 11362
5 GRAPHIC image_004.jpg GRAPHIC 10855
6 GRAPHIC image_004a.jpg GRAPHIC 30789
7 GRAPHIC image_005.jpg GRAPHIC 34402
8 GRAPHIC image_006.jpg GRAPHIC 14916
9 GRAPHIC image_007.jpg GRAPHIC 17745
10 GRAPHIC image_008.jpg GRAPHIC 11253
11 GRAPHIC image_009.jpg GRAPHIC 22650
12 GRAPHIC image_010.jpg GRAPHIC 15414
13 GRAPHIC image_011.jpg GRAPHIC 18536
14 GRAPHIC image_012.jpg GRAPHIC 23274
15 GRAPHIC image_013.jpg GRAPHIC 46910
16 GRAPHIC img_0013.jpg GRAPHIC 13369
  Complete submission text file 0001213900-20-037777.txt   2491107
Mailing Address ALTER POSTPLATZ 2 STANS V8 CH-6370
Business Address ALTER POSTPLATZ 2 STANS V8 CH-6370 41-79-779-60-00
NLS Pharmaceutics Ltd. (Filer) CIK: 0001783036 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-236797 | Film No.: 201322148
SIC: 2834 Pharmaceutical Preparations